Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating curcumin to treat unfavorable bleeding patterns in contraceptive implant users has completed and results have been posted. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Bleeding, Implants | Phase 4 | Status: COMPLETED | Results posted: 2024-07-03